SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-067951
Filing Date
2024-06-03
Accepted
2024-06-03 16:05:12
Documents
13
Period of Report
2024-05-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asmb-20240529.htm   iXBRL 8-K 84031
2 EX-10.1 asmb-ex10_1.htm EX-10.1 166312
3 EX-10.2 asmb-ex10_2.htm EX-10.2 54100
  Complete submission text file 0000950170-24-067951.txt   468694

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT asmb-20240529.xsd EX-101.SCH 30855
16 EXTRACTED XBRL INSTANCE DOCUMENT asmb-20240529_htm.xml XML 4710
Mailing Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 241013575
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)